scholarly journals Hemodialysis arteriovenous fistula as first option not necessary in elderly patients

2016 ◽  
Vol 63 (5) ◽  
pp. 1326-1332 ◽  
Author(s):  
Jie Cui ◽  
David Steele ◽  
Julia Wenger ◽  
Tatsuo Kawai ◽  
Fengyong Liu ◽  
...  
Author(s):  
Priti meena ◽  
Vinant bhargava ◽  
Sumit Sehrawat ◽  
Devinder Singh Rana ◽  
Anil Kumar Bhalla ◽  
...  

Author(s):  
Peiyun Liu ◽  
Suh Chien Pang ◽  
Huihua Li ◽  
Ru Yu Tan ◽  
Ren Kwang Alvin Tng ◽  
...  

Radiology ◽  
2018 ◽  
Vol 289 (1) ◽  
pp. 238-247 ◽  
Author(s):  
Farah Gillan Irani ◽  
Terence Kiat Beng Teo ◽  
Kiang Hiong Tay ◽  
Win Htet Yin ◽  
Hlaing Hlaing Win ◽  
...  

Vascular ◽  
2021 ◽  
pp. 170853812110396
Author(s):  
Feng Zhu ◽  
Yao Yao ◽  
Hongbo Ci ◽  
Alimujiang Shawuti

Objective The aim of this study is to investigate the potential association of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with the primary patency of percutaneous transluminal angioplasty (PTA) in hemodialysis arteriovenous fistula (AVF) stenosis. Methods This study conducted a retrospective review of patients with end-stage renal disease referred for hemodialysis AVF stenosis in one center. The study consisted of 114 patients with significant (significant stenosis was defined as a reduction in the caliber of the fistula vein of > 50% with respect to the non-aneurysmal venous segment). AVF stenosis patients were treated with PTA, with conventional balloon angioplasty. The NLR and PLR were calculated from the pre-interventional blood samples. The patients were classified into two groups: group A, primary patency < 12 months ( n = 35) and group B, and primary patency ≥ 12 months ( n = 79). Comparisons between the groups were performed using the Mann–Whitney U test. Kaplan–Meier analysis was performed to compare the factors, NLR and PLR, for association with primary patency AVFs. A receiver-operating characteristic curve analysis was performed to identify the sensitivity and specificity of the NLR and PLR cut-off values in the prediction of primary patency time. Results There was no difference in gender; age; side of AVF; AVF type; comorbid diseases such as diabetes mellitus and hypertension; or blood parameters such as white cell count, erythrocytes, hemoglobin, neutrophils, lymphocytes, monocytes, eosinophils, basophils, C-reactive protein, NLR, or PLR between the two groups ( p > 0.05). There was also no significant difference in the patency rate between the NLR < 4.13 and NLR ≥ 4.13 groups at 12 months (NLR cut-off point = 4.13, p = 0.273). There were statistically significant differences between the primary patency rates of the PLR < 187.86 and PLR ≥ 187.86 groups at 12 months (PLR cut-off point = 187.86, p = 0.023). The cut-off value for PLR for the determination of primary patency was 187.86, with a sensitivity of 57.0% and specificity of 34.4%. Conclusion An increased level of PLR may be a risk factor for the development of early AVF restenosis after successful PTA. However, more studies are needed to validate this finding.


Sign in / Sign up

Export Citation Format

Share Document